Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma

Oncogene volume 23, pages 4146–4154 (2004)Cite this article

Abstract

Macrophage migration inhibitory factor (MIF) has been linked to fundamental processes such as control of cell proliferation, cell survival, angiogenesis, and tumor progression. The expression of MIF has been reported in several tumors. However, the precise role of MIF in tumor cells remains unclear. In the present study, we investigated the expression pattern and the function of MIF in neuroblastoma. Our results showed that intracellular MIF was upregulated in neuroblastoma tumor tissues and cell lines. MIF protein expression significantly correlated with the grade of tumor differentiation. In addition, we found that MIF induced a significant dose-dependent increase of vascular endothelial growth factor and interleukin-8 secretion. We also observed that an increased MIF expression level correlated with N-Myc protein (the N-myc oncogene product) expression in neuroblastoma tissues. MIF increased the expression of N-myc mRNA and N-Myc protein and induced N-Myc translocation from the cytoplasm to nucleus in neuroblastoma cell lines. MIF-induced N-Myc expression was found to be dependent on ERK signaling pathways. The inhibition of ERK activation reduced MIF-mediated N-Myc expression. These results suggest that MIF may contribute to the progression of neuroblastoma by (a) inducing N-Myc expression and (b) upregulating the expression of angiogenic factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akbar SM, Abe M, Murakami H, Tanimoto K, Kumagi T, Yamashita Y, Michitaka K, Horiike N and Onji M . (2001). Cancer Lett., 171, 125–132.

  • Beryckere F and Gannon F . (1994). Biotechniques, 16, 405.

  • Bin Q, Johnson BD, Schauer DW, Casper JT and Orentas RJ . (2002). Tumour Biol., 23, 123–129.

  • Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF and Tosi P . (1997). Electrophoresis, 18, 2832–2841.

  • Bown N . (2001). J. Clin. Pathol., 54, 897–910.

  • Breit S, Ashman K, Wilting J, Rossler J, Hatzi E, Fotsis T and Schweigerer L . (2000). Cancer Res., 60, 4596–4601.

  • Brodeur GM and Nakagawara A . (1992). Am. J. Pediatr. Hematol. Oncol., 14, 111–116.

  • Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM . (1984). Science, 224, 1121–1124.

  • Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL and Schnitt SJ . (1995). Hum. Pathol., 26, 86–91.

  • Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF . (1993). Cancer Res., 53, 4727–4735.

  • Carmeliet P and Jain RK . (2000). Nature, 407, 249–257.

  • Chambery D, Mohseni-Zadeh S, de Galle B and Babajko S . (1999). Cancer Res., 59, 2898–2902.

  • Chesney J, Metz C, Bacher M, Peng T, Meinhardt A and Bucala R . (1999). Mol. Med., 5, 181–191.

  • David JR . (1966). Proc. Natl. Acad. Sci. USA, 56, 72–77.

  • Desbaillets I, Diserens AC, Tribolet N, Hamou MF and Van Meir EG . (1997). J. Exp. Med., 186, 1201–1212.

  • Dvorak HF, Brown LF, Detmar M and Dvorak AM . (1995). Am. J. Pathol., 146, 1029–1039.

  • Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM and Himelstein BP . (2000). Clin. Cancer Res., 6, 1900–1908.

  • Ferrer FA, Pantschenko AG, Miller LJ, Anderson K, Grunnet M, McKenna PH and Kreutzer D . (2000). J. Urol., 164, 1016–1020.

  • Fidler IJ and Ellis LM . (1994). Cell, 79, 185–188.

  • Folkman J and Klagsbrun M . (1987). Science, 235, 442–447.

  • Gille J, Swerlick RA and Caughman SW . (1997). EMBO J., 16, 750–759.

  • Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ and Beach DH . (1999). J. Exp. Med., 190, 1375–1382.

  • Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H, Ogata A, Shindoh M, Ohbuchi T and Kawakami Y . (2000). Cancer, 89, 334–341.

  • Karkkainen MJ and Petrova TV . (2000). Oncogene, 19, 5598–5605.

  • Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG and Strieter RM . (1992). Science, 258, 1798–1801.

  • Langer I, Vertongen P, Perret J, Fontaine J, Atassi G and Robberecht P . (2000). Med. Pediatr. Oncol., 34, 386–393.

  • Lasorella A, Noseda M, Beyna M, Yokota Y and Iavarone A . (2000). Nature, 407, 592–598.

  • Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA and Bucala R . (2003). J. Exp. Med., 197, 1467–1476.

  • Maris JM and Matthay KK . (1999). J. Clin. Oncol., 17, 2264–2279.

  • Mattern J, Koomagi R and Volm M . (1996). Br. J. Cancer, 73, 931–934.

  • Meister B, Grunebach F, Bautz F, Brugger W, Fink FM, Kanz L and Mohle R . (1999). Eur. J. Cancer, 35, 445–449.

  • Meitar D, Crawford SE, Rademaker AW and Cohn SL . (1996). J. Clin. Oncol., 14, 405–414.

  • Meyer-Siegler K and Hudson PB . (1996). Urology, 48, 448–452.

  • Misawa A, Hosoi H, Arimoto A, Shikata T, Akioka S, Matsumura T, Houghton P and Sawada T . (2000). Cancer Res., 60, 64–69.

  • Mitchell RA and Bucala R . (2000). Semin. Cancer Biol., 10, 359–366.

  • Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T and Todo S . (2000). Cytokine, 12, 309–314.

  • Pritchard J and Hickman JA . (1994). Lancet, 344, 869–870.

  • Ren Y, Tsui HT, Poon RTP, Li Z, Chen YX, Lau C, Yu WC, Bacher M and Fan ST . (2003). Int. J. Cancer, 107, 22–29.

  • Rossler J, Breit S, Havers W and Schweigerer L . (1999). Int. J. Cancer, 81, 113–117.

  • Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY and Hammond D . (1985). N. Engl. J. Med., 313, 1111–1116.

  • Seeger RC, Wada R, Brodeur GM, Moss TJ, Bjork RL, Sousa L and Slamon DJ . (1988). Prog. Clin. Biol. Res., 271, 41–49.

  • Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK and Castleberry RP . (1999). Cancer, 86, 364–372.

  • Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M and Nishihira J . (1999). Biochem. Biophys. Res. Commun., 264, 751–758.

  • Singh RK, Gutman M, Radinsky R, Bucana CD and Fidler IJ . (1994). Cancer Res., 54, 3242–3247.

  • Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA and Strieter RM . (1994). J. Exp. Med., 179, 1409–1415.

  • Tweddle DA, Malcolm AJ, Cole M, Pearson AD and Lunec J . (2001). Am. J. Pathol., 158, 2067–2077.

  • Wada RK, Pai DSN, Huang J, Yamashiro JM and Sidell N . (1997). Cancer Lett., 121, 181–188.

  • Yang Y, Degranpre P, Kharfi A and Akoum A . (2000). J. Clin. Endocrinol. Metab., 85, 4721–4727.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Hong Kong, Hong Kong, SAR, China

    Yi Ren, Hiu Man Chan, Zhi Li, Chenlung Lin, Ping Ying Lee, Vincent Lui & Paul Kwong Hang Tam

  2. Department of Pathology, The University of Hong Kong, Hong Kong, SAR, China

    John Nicholls

  3. Department of Pediatrics, The University of Hong Kong, Hong Kong, SAR, China

    Chi Fong Chen

  4. Institute of Immunology, Philipps-University Marburg, Germany

    Michael Bacher

Authors
  1. Yi Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiu Man Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chenlung Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John Nicholls
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chi Fong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ping Ying Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vincent Lui
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michael Bacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Paul Kwong Hang Tam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yi Ren or Paul Kwong Hang Tam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, Y., Chan, H., Li, Z. et al. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23, 4146–4154 (2004). https://doi.org/10.1038/sj.onc.1207490

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207490

Keywords

This article is cited by

Search

Advanced search

Quick links